web analytics
December 10, 2016 / 10 Kislev, 5777
Sections
Sponsored Post
The Migdal Ohr Mishpachton MISHPACHTONIM – Israel’s Children are Your Children.

Support Migdal Ohr by purchasing letters in the Torah Scroll that will be written in honor of Rabbi Grossman’s 70th Birthday.



Israeli Company Wins FDA Approval For Bone Cancer Treatment


Printer-Ready Page Layout
JewishPress Logo



Israeli med-tech company InSightec Image Guided Treatment has announced that it has been approved for US Food and Drug Administration (FDA) premarketing of its ExAblate targeted focused ultrasound treatment for the removal of bone tumors.

According to Globes online business magazine, the initial approval is for patients who cannot or will not undergo radiation therapy.

According to InSightec, 30% of bone cancer patients cannot undergo radiation treatment.

InSightec is controlled by Elbit Medical Technologies.

Malkah Fleisher

About the Author: Malkah Fleisher is a graduate of Cardozo Law School in New York City. She is an editor/staff writer at JewishPress.com and co-hosts a weekly Israeli FM radio show. Malkah lives with her husband and two children on the Mount of Olives in Jerusalem.


If you don't see your comment after publishing it, refresh the page.

Our comments section is intended for meaningful responses and debates in a civilized manner. We ask that you respect the fact that we are a religious Jewish website and avoid inappropriate language at all cost.

If you promote any foreign religions, gods or messiahs, lies about Israel, anti-Semitism, or advocate violence (except against terrorists), your permission to comment may be revoked.





Imported and Older Comments:


Current Top Story
ExxonMobile Chairman and CEO Rex Tillerson meets with Russian Premier Vladimir Putin in 2012.
Trump’s Secy of State Expected to be ExxonMobile CEO Rex Tillerson

Printed from: http://www.jewishpress.com/news/israeli-company-wins-fda-approval-for-bone-cancer-treatment/2012/10/22/

Scan this QR code to visit this page online: